Osborne becomes Hansen’s interim CFO
This article was originally published in Clinica
Medical robotics expert Hansen Medical has begun searching for a new CFO, following Steve Van Dick’s resignation after four years in the position. Peter Osborne will serve as CFO on an interim basis until a permanent replacement is found. Before joining Mountain View, California-based Hansen, Mr Osborne worked as an independent consultant providing senior-level financial consulting services to companies since August 2009. He previously served as CFO, treasurer and vice-president of finance and administration at VNUS Medical Technologies, a firm focused on developing technology to treat varicose veins.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals